Indofarma Tbk (INAF) - Cash Flow Conversion Efficiency

Latest as of March 2025: 0.024x

Based on the latest financial reports, Indofarma Tbk (INAF) has a cash flow conversion efficiency ratio of 0.024x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp-18.71 Billion ≈ $-1.10 Million USD) by net assets (Rp-788.96 Billion ≈ $-46.23 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Indofarma Tbk market capitalisation for the company's overall valuation and market capitalisation.

Indofarma Tbk - Cash Flow Conversion Efficiency Trend (2000–2024)

This chart illustrates how Indofarma Tbk's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Indofarma Tbk Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Indofarma Tbk ranked by their cash flow conversion efficiency. Explore INAF cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Pulsenmore Ltd TA:PULS	-0.196x
Morgan Sindall Group PLC LSE:MGNS	-0.017x
Key ASIC Bhd KLSE:0143	0.182x
TherapeuticsMD Inc NASDAQ:TXMD	0.051x
Chien Wei Precise Technology Co Ltd TWO:8092	0.096x
Mistral Iberia Real Estate SOCIMI S.A. MC:YMIB	-0.026x
Actuate Therapeutics, Inc. Common stock NASDAQ:ACTU	-0.611x
Loop Industries Inc NASDAQ:LOOP	0.102x

Annual Cash Flow Conversion Efficiency for Indofarma Tbk (2000–2024)

The table below shows the annual cash flow conversion efficiency of Indofarma Tbk from 2000 to 2024. View current stock price of Indofarma Tbk for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Rp-1.14 Trillion ≈ $-67.04 Million	Rp-21.65 Billion ≈ $-1.27 Million	0.019x	-91.99%
2023-12-31	Rp-804.15 Billion ≈ $-47.12 Million	Rp-190.10 Billion ≈ $-11.14 Million	0.236x	+126.88%
2022-12-31	Rp86.35 Billion ≈ $5.06 Million	Rp-75.95 Billion ≈ $-4.45 Million	-0.880x	-581.24%
2021-12-31	Rp508.31 Billion ≈ $29.78 Million	Rp92.90 Billion ≈ $5.44 Million	0.183x	+68.96%
2020-12-31	Rp430.33 Billion ≈ $25.22 Million	Rp46.55 Billion ≈ $2.73 Million	0.108x	+162.70%
2019-12-31	Rp504.94 Billion ≈ $29.59 Million	Rp20.79 Billion ≈ $1.22 Million	0.041x	+129.05%
2018-12-31	Rp496.65 Billion ≈ $29.10 Million	Rp-70.39 Billion ≈ $-4.12 Million	-0.142x	-150.69%
2017-12-31	Rp526.41 Billion ≈ $30.85 Million	Rp147.18 Billion ≈ $8.62 Million	0.280x	+150.63%
2016-12-31	Rp575.76 Billion ≈ $33.74 Million	Rp-317.96 Billion ≈ $-18.63 Million	-0.552x	-343.75%
2015-12-31	Rp592.71 Billion ≈ $34.73 Million	Rp134.28 Billion ≈ $7.87 Million	0.227x	-9.82%
2014-12-31	Rp591.96 Billion ≈ $34.69 Million	Rp148.73 Billion ≈ $8.71 Million	0.251x	+204.81%
2013-12-31	Rp590.79 Billion ≈ $34.62 Million	Rp-141.62 Billion ≈ $-8.30 Million	-0.240x	-280.88%
2012-12-31	Rp650.10 Billion ≈ $38.09 Million	Rp-40.91 Billion ≈ $-2.40 Million	-0.063x	-230.42%
2011-12-31	Rp609.19 Billion ≈ $35.70 Million	Rp29.40 Billion ≈ $1.72 Million	0.048x	-36.66%
2010-12-31	Rp311.27 Billion ≈ $18.24 Million	Rp23.71 Billion ≈ $1.39 Million	0.076x	-43.89%
2009-12-31	Rp298.72 Billion ≈ $17.50 Million	Rp40.56 Billion ≈ $2.38 Million	0.136x	+121.50%
2008-12-31	Rp296.60 Billion ≈ $17.38 Million	Rp-187.31 Billion ≈ $-10.98 Million	-0.632x	-320.73%
2007-12-31	Rp291.56 Billion ≈ $17.08 Million	Rp83.42 Billion ≈ $4.89 Million	0.286x	+9.70%
2006-12-31	Rp280.49 Billion ≈ $16.44 Million	Rp73.15 Billion ≈ $4.29 Million	0.261x	+226.07%
2005-12-31	Rp265.25 Billion ≈ $15.54 Million	Rp-54.87 Billion ≈ $-3.22 Million	-0.207x	-133.21%
2004-12-31	Rp255.67 Billion ≈ $14.98 Million	Rp159.25 Billion ≈ $9.33 Million	0.623x	+310.06%
2003-12-31	Rp267.94 Billion ≈ $15.70 Million	Rp40.70 Billion ≈ $2.39 Million	0.152x	+64.33%
2000-12-31	Rp292.57 Billion ≈ $17.14 Million	Rp27.05 Billion ≈ $1.58 Million	0.092x	--

About Indofarma Tbk

JK:INAF Indonesia Drug Manufacturers - Specialty & Generic

Market Cap

$22.88 Million

Rp390.51 Billion IDR

Market Cap Rank

#24770 Global

#528 in Indonesia

Share Price

Rp126.00

Change (1 day)

+0.00%

52-Week Range

Rp126.00 - Rp126.00

All Time High

Rp6975.00